NVAX
8K. Dilución ATM de 250 millones de acciones
sale of up to $250,000,000 of shares of the Company’s common stock (the “Shares”) from time to time in at-the-market offerings pursuant to an At Market Issuance Sales Agreement with B. Riley FBR, Inc. (the “Sales Agent”), dated as of May 18, 2020
Between April 1, 2020 and May 12, 2020, the Company sold 4.8 million shares of its common stock resulting in $99.3 million in net proceeds at a weighted average sales price of $21.08 per share pursuant to its At Market Issuance Sales Agreement with B. Riley FBR, Inc., dated as of March 2, 2020 (the “March 2020 Sales Agreement”), fully utilizing the March 2020 Sales Agreement as of May 12, 2020.
http://ir.novavax.com/node/14651/html